Study guide
5.4 Vascular Diseases & Hypertension Management
USMLE Step 3 Exam
Track your progress as you read
Finished sections get a check mark.
1 Foundations - Biostatistics & Study Design
1.1 Study Designs & Clinical Trials 1.2 Hypothesis Testing & Statistical Significance 1.3 Measures of Association & Diagnostic Accuracy
2 Foundations - Epidemiology & Literature Interpretation
Section 2.1: Epidemiology & Risk Measures Section 2.2: Interpretation of Medical Literature & Ads Section 2.3: Preventive Medicine & Screening Guidelines
3 Foundations - Ethics & Communication
3.1 Medical Ethics & Patient Autonomy 3.2 Professionalism & Communication Skills 3.3 Legal Medicine & Informed Consent
4 Foundations - Patient Safety & Systems
Section 4.1: Patient Safety & Error Reduction Section 4.2: Quality Improvement & Systems-Based Practice Section 4.3: Healthcare Delivery Systems & Transitions of Care
5 Cardiovascular Management
5.1 Ischemic Heart Disease & Myocardial Infarction 5.2 Heart Failure & Cardiomyopathies 5.3 Arrhythmias & Conduction System Disorders 5.4 Vascular Diseases & Hypertension Management
6 Respiratory Management
Section 6.1: Obstructive Lung Diseases Section 6.2: Restrictive & Interstitial Lung Diseases Section 6.3: Infectious Pulmonary Diseases Section 6.4: Pulmonary Vascular & Pleural Diseases
7 Gastrointestinal & Hepatic Management
Esophageal & Gastric Disorders Intestinal & Colorectal Disorders Hepatic, Biliary, & Pancreatic Diseases Nutritional & Malabsorptive Syndromes
8 Renal, Urinary, & Endocrine Management
Section 8.1: Acute Kidney Injury & Chronic Kidney Disease Section 8.2: Fluid, Electrolyte, & Acid-Base Disorders Section 8.3: Diabetes Mellitus & Metabolic Syndrome Section 8.4: Thyroid, Adrenal, & Pituitary Disorders
9 Neurology, Special Senses, & Behavioral Health
9.1 Cerebrovascular Disease & Stroke 9.2 Neurodegenerative & Demyelinating Disorders 9.3 Psychiatric Emergencies & Substance Use Disorders 9.4 Common Mood, Anxiety, & Psychotic Disorders
10 Obstetrics & Gynecology
10.1 Antepartum Care & Pregnancy Complications 10.2 Intrapartum Management & Postpartum Care 10.3 Gynecology & Breast Disorders
11 Pediatrics, Human Development, & Multisystem Care
11.1 Normal Development & Childhood Immunizations 11.2 Common Pediatric & Neonatal Illnesses 11.3 Multisystem & Rheumatologic Diseases
12 Skin, Musculoskeletal, & CCS Case Management
Section 12.1: Common Dermatologic Presentations Section 12.2: Acute & Chronic Musculoskeletal Injuries Section 12.3: Computer-Based Case Simulations (CCS) Strategy
5.4 Vascular Diseases & Hypertension Management
Key Takeaways Explain This Topic AI
Stanford Type A aortic dissection involves the ascending aorta and requires emergency surgical repair; Type B is managed medically with IV beta-blockers (esmolol, labetalol) to reduce shear stress.
Abdominal aortic aneurysm screening is recommended once for men aged 65-75 who have ever smoked, using abdominal ultrasound; elective surgical repair is indicated for size ≥ 5.5 cm or rapid growth.
Hypertensive emergency is defined by severe BP elevation with acute target-organ damage, requiring ICU admission and IV drug titration to lower mean arterial pressure by no more than 25% in the first hour.
Last updated: July 2026
Vascular Diseases & Hypertension Management
Step 3 Clinical Focus: Cardiovascular vascular pathology and hypertensive emergencies represent critical areas on the USMLE Step 3. Key objectives include diagnosing and managing aortic dissection, executing screening guidelines and intervention thresholds for abdominal aortic aneurysms (AAA), managing peripheral arterial disease (PAD), and distinguishing hypertensive urgency from emergency with appropriate blood pressure lowering strategies.
Aortic Dissection
Aortic dissection involves a tear in the aortic intima, allowing blood to flow into the media and create a false lumen. It is classified by the Stanford system. Type A involves the ascending aorta and is a surgical emergency due to the risk of extension into the aortic valve (causing acute aortic regurgitation), coronary arteries (causing myocardial infarction, typically inferior wall), or pericardial space (causing cardiac tamponade). Type B involves the descending aorta only (distal to the left subclavian artery) and is managed medically unless end-organ ischemia, rupture, or uncontrollable pain occurs. Risk factors include chronic hypertension, cocaine use, bicuspid aortic valve, and connective tissue disorders like Marfan syndrome. Patients present with sudden, tearing or ripping chest pain radiating to the back. Examination may reveal a blood pressure differential (> 20 mmHg) between the arms, asymmetric pulses, and a diastolic murmur of aortic regurgitation. Diagnosis is confirmed with CT angiography in stable patients, or transesophageal echocardiography (TEE) in unstable patients or those with renal impairment.
Management of Type A requires immediate surgical consultation and rapid blood pressure control. For Type B, medical therapy is first-line, aimed at reducing shear stress on the aortic wall by lowering heart rate and contractility (dP/dt). Intravenous beta-blockers, such as labetalol (acting on both alpha-1 and beta receptors) or esmolol (ultra-short-acting and easily titratable), are the first-line therapy, titrated to a target heart rate < 60 beats per minute and a systolic blood pressure of 100 to 120 mmHg. Vasodilators like sodium nitroprusside should only be added after adequate beta-blockade has been achieved; administering vasodilators alone causes reflex tachycardia and increased contractility, propagating the dissection. Additionally, sodium nitroprusside carries a risk of cyanide toxicity, particularly in patients with renal failure.
Abdominal Aortic Aneurysm (AAA)
An AAA is a localized dilation of the abdominal aorta ≥ 3.0 cm, typically caused by atherosclerotic degradation of the arterial wall. Smoking is the strongest modifiable risk factor. The USPSTF recommends a one-time screening with abdominal duplex ultrasound for men aged 65 to 75 who have ever smoked (defined as ≥ 100 cigarettes in their lifetime). There is no screening recommendation for women or men who have never smoked.
AAA Surveillance and Intervention Guidelines
The following table summarizes the standard surveillance intervals and surgical referral thresholds based on AAA diameter:
- AAA Diameter Surveillance / Action Required
- 3.0 to 3.9 cm Repeat ultrasound every 3 years
- 4.0 to 4.9 cm Repeat ultrasound every 12 months
- 5.0 to 5.4 cm Repeat ultrasound every 6 months
- ≥ 5.5 cm Referral for elective surgical repair
- Rapid Expansion Surgical repair if growth is ≥ 0.5 cm within 6 months
- Symptomatic Surgical repair regardless of size (abdominal/back pain, tenderness)
Surgical repair can be performed via open surgery or endovascular aneurysm repair (EVAR). While EVAR has a lower 30-day mortality, it requires lifelong imaging surveillance to monitor for endoleaks. Ruptured AAA is highly fatal (up to 90% mortality) and presents with severe abdominal pain, hypotension, and a pulsatile mass, requiring immediate emergency surgery.
Peripheral Arterial Disease (PAD)
PAD is caused by systemic atherosclerosis leading to stenosis of peripheral arteries, presenting as intermittent claudication (exertional muscle pain relieved by rest) or critical limb ischemia (rest pain, gangrene). Rest pain is classically worse when lying flat in bed and improves with dependency, such as dangling the leg over the edge of the bed. The initial diagnostic test is the Ankle-Brachial Index (ABI). An ABI ≥ 0.90 is diagnostic. In patients with non-compressible, calcified vessels (diabetics), the ABI can be falsely elevated (> 1.30); in these cases, a Toe-Brachial Index (TBI) should be obtained. Management involves smoking cessation, high-intensity statin therapy, and antiplatelet therapy (aspirin or clopidogrel) to reduce cardiovascular mortality. A structured, supervised exercise program is the first-line therapy for claudication. Cilostazol (a phosphodiesterase inhibitor with vasodilator and antiplatelet properties) can be added if exercise is insufficient; it is contraindicated in patients with heart failure of any severity due to increased mortality. Revascularization (angioplasty, stenting, or bypass surgery) is reserved for critical limb ischemia or refractory claudication.
Hypertensive Urgency vs. Emergency
Severe hypertension is defined as a systolic blood pressure ≥ 180 mmHg and/or diastolic blood pressure ≥ 120 mmHg. Hypertensive urgency is severe hypertension without acute target-organ damage. Blood pressure should be lowered gradually over 24 to 48 hours using oral agents (clonidine, labetalol, amlodipine) in an outpatient setting to prevent cerebral hypoperfusion. Hypertensive emergency is severe hypertension with acute target-organ damage (encephalopathy, myocardial infarction, pulmonary edema, aortic dissection, acute renal failure) driven by endothelial shear stress and fibrinoid necrosis of arterioles. Patients require admission to an intensive care unit for intravenous medications. First-line agents include labetalol, nicardipine, and clevidipine. Fenoldopam, a selective dopamine D1 agonist, is particularly useful in patients with acute kidney injury as it maintains renal perfusion. The general rule is to lower the mean arterial pressure (MAP) by no more than 25% within the first hour, then to 160/100-110 mmHg over the next 2 to 6 hours. Exceptions include aortic dissection (rapidly lower systolic blood pressure to < 120 mmHg in 20 minutes) and acute ischemic stroke (do not lower blood pressure unless it exceeds 220/120 mmHg, or 185/110 mmHg if a candidate for thrombolysis).